StackTerminal.Health

GHK-Cu

Copper tripeptide used mostly in topical/cosmetic contexts; evidence varies by formulation and endpoint.

goal:skin-hairgoal:daily-baselineconstraint:not-drug-test-safeevidence:moderatestudy:other-unclearpop:general-healthy-adultsform:other
Dosing model
FLATFixed dose (no body-weight scaling).
Min dose
Max dose
Rounding

Stacks containing GHK-Cu

Public community stacks that include this ingredient.

Explore all stacks →
recoveryskinresearch-only

Adds a copper peptide often discussed in cosmetic/skin contexts to a recovery/joint pairing. Evidence is indirect and component-based.

BPC-157
1mg
TB500 (TB4 / Thymosin Beta-4)
1mg
GHK-Cu
1mg
New
View
Evidence
2 records
Wrinkle improvement (objective measures)
Adults using topical copper tripeptide complexClinical study (objective evaluation)
Low

One objective evaluation reported no significant improvement in wrinkles/overall skin quality, though patient satisfaction differed; underscores mixed results across formulations and endpoints.

Dose:
Skin appearance / remodeling (summary of clinical + mechanistic evidence)
Humans (cosmetic/dermatologic contexts) + preclinicalReview
Moderate

Review summarizes reported improvements in some skin measures and broad tissue-remodeling biology; quality and comparators vary widely. The authors note a surprising absence of rigorous modern clinical trials for GHK-Cu in anti-wrinkle applications despite widespread cosmetic use.

Dose:
Forms
Other
Often discussed in topical formulations; vendor lists powder